Cost impact model of a novel multi-mRNA host response assay for diagnosis and risk assessment of acute infections and sepsis in the ED

2021-03-12T12:50:28-07:00

Schneider JE, Romanowsky J, et al. JHEOR. 2020.

Go to Top